July 23, 2025
4 min watch
Healio spoke with Mark Salamango, MS, of AirStrip about their AI-predicative device that gives early warning to foretell and reply to affected person hemodynamic instability.
Key takeaways:
- AirStrip’s predictive device presents early warnings to foretell and reply to affected person hemodynamic instability.
- The device additionally helps determine sufferers at greater danger for decline.
An FDA-cleared predictive analytic device for hemodynamic instability could quickly leverage its success in crucial care to the oncology affected person inhabitants, providing an early warning for high-risk sufferers with most cancers earlier than deterioration.
Many sufferers with most cancers are immunocompromised and at heightened danger for creating sepsis and septic shock. The Analytic for Hemodynamic Instability (AHI) system from San Antonio-based AirStrip Applied sciences predicts hemodynamic instability utilizing noninvasive alerts, permitting suppliers to anticipate affected person decline and start early interventions.
“Once we began, we had been an all-cause detector of hemodynamic instability, however as we began to evaluation specific-use instances, we discovered that this was good for postpartum hemorrhage and sepsis detection,” Mark Salamango, MS, founder, chief know-how officer and director of Fifth Eye Inc., instructed Healio. “After speaking with CancerX, we’re seeing that there are actual-use instances for remedies and guiding therapies for sufferers with most cancers. One of many issues that AHI can detect is cytokine launch syndrome, which tends to be one of many artifacts from giving sufferers T-cell engagers and CAR T-cell therapies to assist them with their remedy.”
In June 2025, AirStrip introduced it had acquired Fifth Eye, a transfer that Salamango is “enthusiastic about” as it’ll leverage digital well being file information and danger insights right into a single, unified early-detection dashboard for clinicians.
“We have now a predictive analytic, in addition to the remainder of the EHR data for a affected person, so you may actually get a 360-degree view of what’s going on with a particular affected person, or simply determine which higher-risk sufferers could also be effervescent as much as the highest that you might want to spend extra time with,” he stated.
AirStrip has been named one among simply 14 startups chosen for the distinguished 2025 CancerX Accelerator cohort, a extremely aggressive program on the forefront of digital well being innovation in oncology.
CancerX, a nationwide initiative hosted by Moffitt Most cancers Heart in collaboration with the Workplace of the Nationwide Coordinator for Well being Info Know-how and the Workplace of the Assistant Secretary for Well being, brings collectively modern startups leveraging digital well being and AI to deal with probably the most urgent challenges in most cancers care.
The CancerX Accelerator program gives startups with direct entry to business champions, mentors and a sturdy community of specialists. Startups additionally profit from tailor-made product suggestions, pilot alternatives with main well being care organizations and the potential for business agreements.
“The very best recommendation I can provide for [future CancerX cohorts] is to be as current and concerned as you may, hold reaching out to these champions and discover out what the wants are,” Salamango stated. “Whereas it’s enjoyable to be an engineer and construct one thing, the fact is that we have to guarantee that all the pieces we’re constructing has a particular goal and particular buyer, so we will direct the product to the locations it must go.”
On this video, Salamango shares insights into why he opted to take part within the CancerX Accelerator, the avenues it has opened to the corporate and the way a easy problem to discover a higher method to assess sufferers within the “muddy center” sparked a journey to radical innovation in most cancers care.
Because the official media companion of the CancerX 2025 Accelerator cohort, Healio will showcase key breakthroughs and achievements by unique interviews with this 12 months’s startups in addition to alumni teams from the 2024 program.
Functions for the 2026 CancerX Accelerator cohort will open Sept. 2, 2025, solely for CancerX members, with public functions opening Sept. 9, 2025. Be a part of the CancerX neighborhood right here.
References:
For extra data:
Mark Salamango, MS, could be reached on LinkedIn right here.
